Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This is a controlled study to determine the effectiveness and safety of ethyl icosapentate
(EPA-E) in the treatment of adult patients with non-alcoholic steatohepatitis (NASH).